Jodi V Fox-mellul, MD | |
34 Colson Ln, Mullica Hill, NJ 08062-1502 | |
(856) 223-0965 | |
(856) 223-1357 |
Full Name | Jodi V Fox-mellul |
---|---|
Gender | Female |
Speciality | Endocrinology |
Experience | 22 Years |
Location | 34 Colson Ln, Mullica Hill, New Jersey |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053616631 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 049417 (Connecticut) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Inspira Medical Center Elmer | Elmer, NJ | Hospital |
Inspira Medical Center Vineland | Vineland, NJ | Hospital |
Penn Presbyterian Medical Center | Philadelphia, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Inspira Health Network Medical Group Pc | 4880797570 | 178 |
News Archive
Allergan, Inc. has announced the U.S. Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) voted unanimously (9-0) to recommend that the FDA approve LATISSE (bimatoprost solution 0.03%) as a treatment for hypotrichosis (or reduced amount of hair) of the eyelashes.
Life-threatening fungal infections affect more than two million people worldwide. Effective antifungal medications are very limited.
New research in the latest issue of the Society of Chemical Industry's (SCI) Journal of the Science of Food and Agriculture shows there is no evidence to support the argument that organic food is better than food grown with the use of pesticides and chemicals.
Inhibitex, Inc. today reported positive top-line safety and antiviral data from its multiple ascending dose Phase 1b clinical trial of INX-189, an oral nucleotide polymerase inhibitor being developed to treat chronic infections caused by hepatitis C virus.
› Verified 6 days ago
Entity Name | Inspira Health Network Medical Group Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922177856 PECOS PAC ID: 4880797570 Enrollment ID: O20070319000280 |
News Archive
Allergan, Inc. has announced the U.S. Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) voted unanimously (9-0) to recommend that the FDA approve LATISSE (bimatoprost solution 0.03%) as a treatment for hypotrichosis (or reduced amount of hair) of the eyelashes.
Life-threatening fungal infections affect more than two million people worldwide. Effective antifungal medications are very limited.
New research in the latest issue of the Society of Chemical Industry's (SCI) Journal of the Science of Food and Agriculture shows there is no evidence to support the argument that organic food is better than food grown with the use of pesticides and chemicals.
Inhibitex, Inc. today reported positive top-line safety and antiviral data from its multiple ascending dose Phase 1b clinical trial of INX-189, an oral nucleotide polymerase inhibitor being developed to treat chronic infections caused by hepatitis C virus.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Jodi V Fox-mellul, MD 34 Colson Ln, Mullica Hill, NJ 08062-1502 Ph: (856) 223-0965 | Jodi V Fox-mellul, MD 34 Colson Ln, Mullica Hill, NJ 08062-1502 Ph: (856) 223-0965 |
News Archive
Allergan, Inc. has announced the U.S. Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) voted unanimously (9-0) to recommend that the FDA approve LATISSE (bimatoprost solution 0.03%) as a treatment for hypotrichosis (or reduced amount of hair) of the eyelashes.
Life-threatening fungal infections affect more than two million people worldwide. Effective antifungal medications are very limited.
New research in the latest issue of the Society of Chemical Industry's (SCI) Journal of the Science of Food and Agriculture shows there is no evidence to support the argument that organic food is better than food grown with the use of pesticides and chemicals.
Inhibitex, Inc. today reported positive top-line safety and antiviral data from its multiple ascending dose Phase 1b clinical trial of INX-189, an oral nucleotide polymerase inhibitor being developed to treat chronic infections caused by hepatitis C virus.
› Verified 6 days ago
Trina Doreen Banerjee, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 5 Myers Drive Unit 105, Mullica Hill, NJ 08062 Phone: 856-431-6300 Fax: 856-431-6310 | |
Suemair Hassan, DO Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 700 Mullica Hill Rd, Mullica Hill, NJ 08062 Phone: 856-508-8000 | |
Pranav Patel, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 698 Mullica Hill Rd Ste 330, Mullica Hill, NJ 08062 Phone: 856-508-3707 Fax: 856-221-4077 | |
Dr. Erev E Tubb, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 698 Mullica Hill Rd Ste 300, Mullica Hill, NJ 08062 Phone: 856-508-3575 Fax: 856-221-4101 | |
Akshara Kartik, DO Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 700 Mullica Hill Rd, Mullica Hill, NJ 08062 Phone: 856-308-3291 | |
Dr. Anthony Wehbe, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 507 Mullica Hill Road, Mullica Hill, NJ 08062 Phone: 609-455-1576 Fax: 856-218-5664 |